StockData
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. (HRMY) stock

HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.01+0.05 (+0.15%)

Close on Nov 17, 2026Market cap $1.92BP/E 10.7Yield –

Harmony Biosciences gross margin

Gross margin is gross profit as a percentage of revenue.

Harmony Biosciences's gross margin for the twelve months ending Jun 30, 2026 was 75.4%. For fiscal 2025 it was 77.2%, against 78.1% the year before. The highest annual figure on record is 82.6% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202577.2%−0.9
FY2024Dec 31, 202478.1%−1.1
FY2023Dec 31, 202379.2%−1.8
FY2022Dec 31, 202280.9%−0.9
FY2021Dec 31, 202181.8%−0.8
FY2020Dec 31, 202082.6%+8.9
FY2019Dec 31, 201973.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202675.8%−5.2
Q1 FY2026Mar 31, 202679.3%−3.3
Q4 FY2025Dec 31, 202571.9%−1.1
Q3 FY2025Sep 30, 202575.1%−1.9
Q2 FY2025Jun 30, 202581.0%−0.4
Q1 FY2025Mar 31, 202582.7%+0.5
Q4 FY2024Dec 31, 202473.0%−1.4
Q3 FY2024Sep 30, 202477.0%−2.8
Q2 FY2024Jun 30, 202481.4%+0.0
Q1 FY2024Mar 31, 202482.2%−0.3
Q4 FY2023Dec 31, 202374.4%−4.7
Q3 FY2023Sep 30, 202379.8%−0.6
Q2 FY2023Jun 30, 202381.4%−1.0
Q1 FY2023Mar 31, 202382.6%−0.2
Q4 FY2022Dec 31, 202279.0%−1.4
Q3 FY2022Sep 30, 202280.4%−1.5
Q2 FY2022Jun 30, 202282.3%−0.5
Q1 FY2022Mar 31, 202282.8%+0.2
Q4 FY2021Dec 31, 202180.5%−1.9
Q3 FY2021Sep 30, 202181.9%−0.8
Q2 FY2021Jun 30, 202182.8%−0.2
Q1 FY2021Mar 31, 202182.6%+0.1
Q4 FY2020Dec 31, 202082.4%–
Q3 FY2020Sep 30, 202082.7%–
Q2 FY2020Jun 30, 202083.0%–
Q1 FY2020Mar 31, 202082.5%–

More Harmony Biosciences figures

See a number that looks wrong?